Search results
Results from the WOW.Com Content Network
For example, Pakistan uses prices from Bangladesh and India, while Iran uses prices from Greece, Spain, Turkey and the drug country of origin. Drug price data from LMICs can be lacking, and in such situations, international medicine prices can be obtained from the International Medical Products Price Guide. Some countries use ERP for all drug ...
A Guide Book of United States Coins (the Red Book) is the longest running price guide for U.S. coins. Across all formats, 24 million copies have been sold. [2] The first edition, dated 1947, went on sale in November 1946. Except for a one-year hiatus in 1950, publication has continued to the present.
In the United States, the average wholesale price (AWP) is a prescription drug term referring to the average price for medications offered at the wholesale level. [1] The metric was originally intended to convey real pricing information to third-party payers, including government prescription drug programs.
Prescription drug list prices in the United States continually are among the highest in the world. [1] [2] The high cost of prescription drugs became a major topic of discussion in the 21st century, leading up to the American health care reform debate of 2009, and received renewed attention in 2015.
Red Book, one of the progenitors, along with the Green Book of Lloyd's Register; Red Book, nickname for A Guide Book of United States Coins by R. S. Yeoman, an overview and pricing guide; Red Book, US guide for risk assessment by National Research Council; Red Books of Humphry Repton, plans for landscape gardens by British designer Humphry Repton
Whitman Publishing is an American book publishing company which started as a subsidiary of the Western Printing & Lithographing Company of Racine, Wisconsin. In about 1915, Western began printing and binding a line of juvenile books for the Hamming-Whitman Publishing Company of Chicago.
Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the Orange Book, is a publication produced by the United States Food and Drug Administration (FDA), as required by the Drug Price and Competition Act (Hatch-Waxman Act). The Hatch-Waxman Act was created to '"strike a balance between two competing policy interests:
Version 3.0 also included drug transporter data, drug pathway data, drug pricing, patent and manufacturing data as well as data on >5000 experimental drugs. Version 4.0 was released in 2014. [ 4 ] This version included 1558 FDA-approved small molecule drugs, 155 biotech drugs and 4200 unique drug targets.